The hypermorphic PLC?2 S707Y variant dysregulates microglial cell function - insight into PLC?2 activation in brain health and disease, and opportunities for therapeutic modulation (2023)
Attributed to:
Discovering inhibitors of gain-of-function Phospholipase C gamma1 for T-cell lymphomas
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.10.30.564579
Publication URI: http://dx.doi.org/10.1101/2023.10.30.564579
Type: Preprint